Literature DB >> 3000733

Effects of angiotensin II, adrenocorticotropin, and potassium on aldosterone production in adrenal zona glomerulosa cells from streptozotocin-induced diabetic rats.

T Kigoshi, N Imaizumi, S Azukizawa, I Yamamoto, K Uchida, F Konishi, S Morimoto.   

Abstract

Hyporeninemic hypoaldosteronism has been shown to occur in streptozotocin-induced chronic diabetic rats with normokalemia. To test the nature of the aldosterone deficiency, we investigated the responses of aldosterone production to angiotensin II (AII), ACTH, and potassium in adrenal zona glomerulosa cells from diabetic rats at 6 weeks after an injection of streptozotocin compared with those in the cells from control rats. In diabetic rats, plasma glucose was high and plasma immunoreactive insulin was low. Diabetic rats also had low levels of PRA and plasma AII, low levels of plasma aldosterone, and normal levels of plasma corticosterone and plasma potassium. The zona glomerulosa width was narrower in diabetic rats than in control rats. Basal aldosterone production, when corrected to an uniform number of cells per group, was similar in the cells from control and diabetic rats. Cells from diabetic rats showed a less sensitive and lower response of aldosterone production to AII, increases in the threshold and the ED50, and a decrease in the maximal AII-stimulated aldosterone level. ACTH, however, caused a similar effect on aldosterone production in the cells from control and diabetic rats. Cells from diabetic rats exhibited a less sensitive response of aldosterone production to potassium and a tendency to be low in the maximal potassium-stimulated aldosterone level, presumably attributable to the impairment of adrenal zona glomerulosa cells to AII. We conclude that the hypoaldosteronism observed in our diabetic rats may be secondary to the deficiency of AII.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3000733     DOI: 10.1210/endo-118-1-183

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Enhanced hemodynamic responses to angiotensin II in diabetes are associated with increased expression and activity of AT1 receptors in the afferent arteriole.

Authors:  Jie Zhang; Helena Y Qu; Jiangping Song; Jin Wei; Shan Jiang; Lei Wang; Liqing Wang; Jacentha Buggs; Ruisheng Liu
Journal:  Physiol Genomics       Date:  2017-08-25       Impact factor: 3.107

2.  The activity of the renin-angiotensin-aldosterone system before and during submaximal bicycle exercise in relation to circulatory catecholamines in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  G Sundkvist; B Bergström; M Bramnert; B Lilja; P Manhem
Journal:  Diabetologia       Date:  1990-03       Impact factor: 10.122

3.  Angiotensin II and glucocorticoid release: direct effect at the adrenal level and modulation of the adrenocorticotropin-induced glucocorticoid release.

Authors:  E Spinedi; L Aguado; G Basilotta; D Carrizo
Journal:  J Endocrinol Invest       Date:  1989-05       Impact factor: 4.256

Review 4.  Therapeutic Renin Inhibition in Diabetic Nephropathy-A Review of the Physiological Evidence.

Authors:  Bianca Domingues Massolini; Stephanie San Gregorio Contieri; Giulia Severini Lazarini; Paula Antoun Bellacosa; Mirela Dobre; Georg Petroianu; Andrei Brateanu; Luciana Aparecida Campos; Ovidiu Constantin Baltatu
Journal:  Front Physiol       Date:  2020-03-12       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.